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CHAPTER I 
INTRODUCTION 
6.-Aminonicotinic acid (6ANA) inhibits the growth of Escherichia 
coli. One possible mechanism is metabolism of 6ANA into the analogue 
of NAD, 6-aminonicotinamide adenine dinucleotide (6ANAD). This 
analogue in turn could stop the de~ biosynthesis of NAD by repression 
and feed back inhibition. Also 6ANAD inhibits some NAD dependent oxido-
reduction enzyme reactions. Unlike many NAD analogues 6ANAD is not 
reducible. 
The effects of 6ANA and 6ANam have been studied extensively in 
mammals. The mechanism of formation of 6ANAD in mammals is through the 
NAD glycohydrolase exchange reaction; however, this enzyme has not been 
detected in!· .££1.i· Therefore, the 6ANA or 6ANam must be metabolized 
by the pyridine nucleotide cycle for conversion into 6ANAD. 
In this study an!· coli mutant W3899n (nad Band pnc A) which 
cannot produce NAD by the de~ pathway has been used. It also 
cannot deaminate Nam to NA. Therefore, the mutant must have an exo-
genous source of NA for growth. 
The following studies were carried out to determine the bacterio-
static mechanism of this compound (6ANA). 6ANA-14c was synthesized 
and incubated with W3899n. The medium and perchloric acid soluable 
cell fraction were then analyzed using conventional chromatography 
techniques. 
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CHAPTER II 
LITERATURE REVIEW 
NAD (nicotinamide adenine dinucleotide) and NADP (nicotinamide 
adenine dinucleotide phosphate) are cofactors to biological oxido-
reduction reactions (1). These cofactors function by accepting an 
hydronium ion at the 4 position of the pyridine ring, (2) and donating 
that hydronium ion to another compound in a reduction reaction. These 
cofactors, NAD and NADP, and their reduced forms, NADH and NADPH, 
participate in over 200 different biological oxido-reduction reactions 
(1) • 
NAD was initially isolated as a dialyzable cofactor required for 
alcohol production from glucose in yeast extracts by Harden and Young 
in 1904 (2). This cofactor ("cozymase" or "coenzyme I") contains 
nicotinamide as established by Albus, Schlenk, and von Euler in 1935 
(3). Another dialyzable cofactor ("coferment" or "coenzyme II") which 
also contained nicotinamide was found by Warburg and Christian (4,5) 
in 1934. These cofactors were different because coferment could not 
substitute for cozymase in the production of alcohol from glucose. 
The elucidation of the structure of these cofactors, NAD and NADP, was 
accomplished by von Euler et !l·, (6,7) and Schlenk (8) in 1937. The 
hydrogen transfer abilities of NAD were elucidated by Warburg and 
Christian (5,9,10), with Pullman et al. later showing that the re-
duction takes place at the 4 position (11). 
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Figure 1. Structures of Nicotinic Acid, 6-Aminonicotinic Acid, 
Nicotinamide, 6-Aminonicotinamide, Pyridine 
Nucleotides, and Pyridine Nucleotide Analogue 
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Biosynthesis of NAD 
While the structure and many of the properties of NAD were 
elucidated by 1954, major features of the de~ biosynthesis were not 
elucidated until the 1960 1s. The de~ biosynthesis begins with the 
condensation of aspartate and dihydroxyacetone-phosphate to form 
quinolinic acid (QA) (12, 13, 14). QA is converted to NaMN with the 
addition of PRPP and loss of co2 (15). NaMN in turn is converted with 
the addition of AMP from ATP to desamido NAD which is then amidated to 
form NAD (16). NADP is produced by the reaction NAD + ATP NADP + ADP 
(17). These reactions are summarized in Figure 2. 
Pyridine Nucleotide Cycle 
!· coli also contain nicotinamide deamidase and NaMN pyrophosphory-
lase, allowing conversion of Nam to NA and NA to NaMN (18). A general 
pyridine nucleotide cycle was proposed by Gholson in 1966 (19). This 
cycle, NaMN des NAD NAD Nam NA NaMN, allows the recovery of 
Nam formed in the breakdown of NAD. 
The degradation of NAD occurs during repair, recombination, or 
synthesis of DNA. A DNA ligase joins strands of DNA at the expense of 
one NAD per junction in the reaction NDA + DNA + NAD 
n m DNAn+m + NMN + 
AMP (20). There has been no evidence of any other enzymes in!· .£2.!!. 
that cleave NAD into NMN and AMP or Nam and ADP-ribose (21). The latter 
reaction is catalyzed by NAD glycohydrolase which is present in 
Mycobacterium butyricuin (22) and Bacillus subtilis (23). Any NMN 
produced from the ligase reaction is either converted into NaMN or into 
Nam and ribose-5-phosphate (21). NMN amidohydrolase deamidates NMN to 
Figure 2, The Pyridine Nucleotide Cycle in 12_ • . .£!:?.!..!. 
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NaMN producing a cycle within a cycle. Olivera has argued that this 
cycle: NaMN des NAD NAD NMN NaMN is the major pathway of 
pyridine nucleotide turnover (24). NMN glycohydrolase splits NMN into 
Nam and R-5-P also completing a pyridine nucleotide cycle: NaMN des 
NAD NAD NMN Nam NA NaMN. 
Genetic Studies of de !!£Y£ Pathway and Pyridine 
Nucleotide Cycle 
The de~ pathway and the pyridine nucleotide cycle have been 
studied using several~· coli mutants. Threee genes in the de~ 
pathway have been defined: nad A, nad B, and nad C. The nad A gene 
maps near minute 17 on the E. coli chromosome and produces quinolinate 
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synthetase A protein (25). That is, QA synthetase B activity is present 
but A activity is not; also QA phosphoribosyl transferase is present in 
nad A mutants. The nad B genes map between pur I and !l!. A at minute 
48 (25, 26). These mutants can be divided into two groups, these that 
complement nad A in vitro and those which do not. The latter lack both 
QA synthetase A and B protein activities and are presumable regulatory 
mutants. This class of mutants has been tentatively designated as nad 
R. 
The nad C mutants lack QA phosphoribosyl transferase. This gene is 
located between leu and pan at approximately minute 1.5 on the genetic 
map (27). Nad C mutants excrete large amounts of QA into the medium 
but addition of pyridine derivatives such as NA, Nam, and NAD, in con-
centrations greater than 2 X 10-6 molar inhibits this excretion. The 
inhibition is due to repression of both the nad A and nad B structural 
gene products (28). 
Tentative evidence suggests that NAD is the metabolically active feed-
back inhibitor of QA synthetase. 
A mutant blocked within the pyridine nucleotide cycle-pnc A-at 
the nicotinamide demidase step has been isolated (29). This mutant 
was produced from a strain (w3899) of!· coli which contained a nad B 
mutation, producing a double mutant (w3899n) blocked in the de~ 
pathway and requiring NA for growth but not able to utilize Nam for 
growth. 
Analogs of NAD 
Analogs of NAD have been used to elaborate the structure of re-
duced NAD, the structure of NADP, in studies on dehydrogenases, and in 
studies on carcinostatic NAD analogs. N-methylnicotinamide and other 
quaternary pyridinium coupounds were used to elaborate the structure 
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of reduced NAD in 1937 (30, 31). The position of the 2 1 monoester 
phosphate group on NADP was determined by using the 3' isomer of NADP 
which was inactive with enqymes which require NADP but not with one 
which uses either NAD or NADP (32). Studies on dehydrogenases have also 
utilized deoxyadenylic NAD (33) and dinicotinamide Ribose 5 1 
-pyrophosphate (34). 
Several analogs of the Nam portion of NAD have also been produced 
using animal tissue NAD glycohydrolase (NADase). Only animal NADase 
will catalize the exchange reaction ARPPN+ + X ARPPX+ + N (35). This 
reaction is inhibited 50% by 1.5 X 10-3 M nicotinamide. Neurospora 
also contains a NAD glycohydrolase which catalyzes NAD hydrolysis but 
not the exchange reaction and is not affected by nicotinamide (36). 
The isonicotinic acid hydrazide analog of NAD was the first such 
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compound studied (36). This analog is not enzymatically reducible but 
-3 10 M analogue has no significant effect on the rate of reduction of 
NAD by yeast alcohol dehydrogenase, horse liver alcohol dehydrogenase, 
transhydrogenase of Pseudomonas, or rabbit muscle lactate dehydrogenase 
(37). This analogue can be cleaved by NADase. 
The 3-acetylpyridine analogue of NAD has also been produced using 
the same reaction as with INH (38). This analogue, howver, is 
enzymatically reducible, as the 4 position is available for reduction. 
The rate of reduction is only 1/20 that of NAD with yeast alcohol de-
hydrogenase. Other analogs are lested in Table I. 
6ANA and 6ANam in Mammallian Systems 
Much work has been done with 6ANA and 6ANam in mammals since it 
was found toxic to rabbits and rats in 1955 (40). At low dosage levels 
6ANam caused paralysis of the extremities and blindness. Further 
studies with rats confirmed the delayed effect of the compound, and it 
was concluded that 6ANam was an antimetabolite of Nam (41). Shapiro, 
Bietrich, and Shils tested 6ANam for carcinostatic activity against 
the 755 mammary adenocarcinoma of mice because 6ANam was such a potent 
antagonist of Nam (42). 6ANam exerted strong antitumor activity 
against the mammary adenocarcinoma and this effect was completely re-
versed by the administration of nicotinamide. Further, radiotherapy in 
combination with treatment with 6ANam was effective in damaging the 
tumors (43). 
The mechanism of action of 6ANam was postulated as conversion to 
the nonphysiological.nucleotide analogues of .NAD and NADP. This 
analogue formation may be irreversible, thus, not allowing the tissue 
-X 
N-R 
x 
0 
II 
-C-NH 2 
9. 
-O-CH3 
0 
-C-H 
P. 
-C-0-C H 2 5 
~ Y2H5 
-C-N-H 
9H 
-9-CH H 3 
-CH 3 
a (39) 
TABLE Ia-
COMPARISON OF REACTIONS OF NAD WITH SOME 
3-SUBSTITUTED PYRIDINE ANALOGUES 
OF NAD 
Reduced by 
Reaction yea~t alcohol 
with cyanide dehydrogenase 
+ + 
+ + 
+ + 
+ 
+ 
11 
Reduced by 
hydrosulfite 
+ 
+ 
+ 
+ 
+ 
to rid itself of the analogue (37). 6ANam was converted to 6ANAD and 
6ANADP in~ and in vitro and the effects of these analogues were 
tested on several NAD dependent enzymatic systems in the 755 tumor. 
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The activities of 3-phosphoglyceraldehyde dehydrogenase, the conversion 
of B-hydroxybutyrate to·acetoacetate, and -ketoglutarate oxidase were 
markedly inhibited, while lactic acid dehydrogenase was unaffected (44). 
6ANam lowers the level of ADP and ATP and greatly increases the concen-
tration of AMP in the 755 tumor. 
A study (Table II) on the energies of molecular orbitals of NAD, 
NADH, and 6ANAD revealed that the lowest empty electronic orbital is 
placed much higher in 6ANAD than in NAD (45). Thus, the analogue does 
not possess the pronounced electron-acceptor properties of the true 
coenzyme and cannot function as an electron carrier in the respiratory 
chain or in other oxidation-reduction reactions (45). 
6ANam has also been used to study the hexose-monophosphate shunt 
as related to glucose induced insulin release, because 6ANam markedly 
reduces oxidation of (1-14c) glucose but does not affect oxidation of 
glucose labelled in C-6. Also pretreatment with 6ANam does not change 
the insulin concentration in the test animals (46, 47). 
Further studies in 6ANam in animal systems include studies on 
behavioral changes in rats (48), effects on erythrocytes (49), effects 
on Na+ and K+ active transport in rat tubular cells (50), and effects 
of 6ANam in the presence of rat brain microsome nucleosidases (51). 
In mammals, the incorporation of 6ANam into 6ANAD does not occur 
primarily through the pyridine nucleotide cycle, but through exchange 
with the NAm portion of NAD by NAD glycohydrolase (51). To·reiterate, 
this enzyme has not been found in[•.££.!..!.. One result of this exchange 
13 
TABLE II8 
ENERGIES OF MOLECULAR ORBITALS 
ComEounds 
NAD+ NADH 6ANAD+ 
Energy of Lowest 
Empty Molecular 
Or'!,ital (ev) -0.356 -0.915 -0.471 
Energy of Highest 
Occupied Molecular 
Orbital (ev) 1.032 0.298 0.735 
a (45) 
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reaction is that in mammals the concentration of 6ANA must be seven 
times that of 6ANam to prod~ce the same effects (52). 
6ANA and 6ANam in Bacterial Systems 
Limited work has been done with 6ANA in bacterial systems. 6ANA 
was first studied as an analogue of p-aminobenzoic acid. It was 
bacteriostatic to E.coli and Streptococcus hemolyticus but not to 
Diplococcus pneumoniae (53). These effects were reversed by PABA. 
In 1970 the folic acid analogue containing 6ANA was synthesized 
to study its antineoplastic activity (54). The analogue was inactive 
against leukemia 11210 in mice and noncytotoxic when tested against 
HE -2 cells in culture. The analogue supported growth of Streptococcus p 
faecalis. 
In a study on bacteriophage in 1951 6ANA suppressed the multi-
plication of the phage but the inhibition could be reversed by Nam or 
PABA or acetic acid (55). 
CHAPTER III 
METHODS AND MATERIALS 
. 14 14 Synthesis of 6ANA- C and 6ANam- C 
The procedure (Figure 3) of Wacker, Lochmann, and Trager (56) was 
used in the preparation of 6ANA-14c. This procedure was also used to 
6AN 14c t th t th 2 · 5 "d" 14c prepare am- excep a e -amino- -cyano-pyri ine- was not 
hydrolyzed with NaOH. Instead, Dowex 50 hydrogen form was added to the 
reaction mixture and heated at 100° for one hour. 14 6ANam- C was re-
moved from the resin with water. The specific activity of the 6ANA-14c 
was 3.2 millicuries per millimole and the specific activity of the 
6ANam-14c was 2.7 millicuries per millimole. The purity of each was 
checked by autoradiography using thin layer chromatography systems I 
and II (57). 
Cultures 
The!· coli mutants, W3899 and W3899n, were maintained in nutrient 
agar slab cultures. New nutrient agar plate cultures used for inocu-
lation were prepared monthly. Each mutant was checked for its genetic 
characteristics before each experiment. Experimental cultures were 
grown in the minimal medium of Yates and Pardee (58) with vigorous 
shaking at 37°. The only addition to this medium was 10-6 molar NA. 
The bacteria were gorwn in volumes of 25 ml, 100 ml, 500, and 10 liters. 
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Figure 3. Synthesis of 6ANA- 14c and 6ANam- 14c 
See Text for Experimental Details. 
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Each culture was inoculated from a starter culture of 5% its volume. 
When the concentration of cells reached approximately 109 cells/ml 
18 
the suspension was centrifuged on a Sorvall RC2-B at 15,000 rpm for 15 
minutes at 4° in a SS-34 head. The 10 liter batch was harvested with 
a Sharples centrifuge. The bacteria were washed with 0.9% NaCl. 
Test Cultures 
The washed cells were resuspended in minimal medium in amounts 
equal to those from which they were harvested. 2 X l0-4M 6ANA-14c and 
-4 14 10 M PABA or an equal concentration of control compound, NA- C, 
14 14 Nam- C, or 6ANam- C-were added to the media. The cultures were shaken 
at 37° for six hours, harvested, washed and suspended in deionized 
water at five milliliters per gram. The suspended cells were sonicated 
at 4°·with a Branson Sonifier at 10 amperes DC for one minute per 20 
milliliters. An equal volume of 15% perchloric acid was immediately 
added to the sonicate. The solution was centrifuged in a Sorvall 
centrafuge for 30 minutes at 20,000 rpm in a SS-34 head. The super-
natant was neutralized to pH 7 with lON KOH and centrifuged at 4°. 
This supernatant was analyzed by ion exchange chromatography. 
Ion Exchange Chromatography 
The medium in which the cells were incubated for six hours and 
the cell extracts were passed through Dowex 1 X 8 formate columns 
(3cm X 60 cm). Water and varying normalities of formic acid were used 
to elute the various compounds, In the case of the medium, cold 
authentic carrier (6ANA and 6ANam - final concentration 10-~) were 
added except when noted. The fractions (lOmls) from the columns were 
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collected on a Buchler fraction collector and absorbance, conductivity 
on a Radiometer conductivity meter, and radioactivity were measured, 
Some fractions were further purified on a Bio-Rad cellex-D anion 
exchange cellulose column (lcm x 40cm) using a NH4Hco3 gradient from 
OM to 0.4 M for elution. 
Spectroscopic Methods 
Spectroscopic studies were made with a Beckman DB spectrophotometer. 
UV and visible light scans of 6ANA and NA compounds were run using a 
0.1 M phosphate buffer at the noted pH's. Columns fractions were 
monitored at A260 unless otherwise specified, using a Gilson automatic 
transferator and a water blank. 
Liquid Scintillation 
Radioactivity was determined using liquidscintillation counting. 
Samples were added to 10 ml of counting liquid in scintillation vials 
and assayed on a Packard Tri-Carb liquid scintillation spectrometer 
series 314A or model 3003. The scintillation liquid was a mixture of 
4 grams PPO, 0.2 grams POPOP, 400 ml ethanol, and 600 ml toluene 
making one liter. The dpm of each sample was calculates using the 
channels ratio.method for quench correction and counting efficiency. 
Quantatative calculations were made assuming the specific activity of 
the labeled remained constant. 
Thin Layer Chromatography 
Thin layer chromatography involved the use of Analtech, Inc. 
cellulose glass plates, 250 microns thick with fluorescent indicator. 
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Also, Brinkmann Polygram eel 300 PEI plates were used. Whatman DE81 
paper was used for all paper chromatography. The solvent systems are 
listed in Table III. 
Enzyme Studies 
NAD was assayed by using the recycling method of Rasmussen, 
Nielsen, and Schack (60). 
Phosphodiesterase (E.C. No. 3.1.4.1) was used in the hydrolysis 
of 6ANAD to 6ANMN and AMP. See Figure 4. The procedure for hydrolysis 
followed Kaplan and Stolzenbach's method (61) for production of NMN 
from NAD except that 6ANAD was substituted for NAD. The products of the 
6ANAD reaction and NAD control reaction were separated on a Dowex 
1 X 2 column. 
NAD glycohydrolase (NADase, E.C. No. 3.2.2.5) from pig brain was 
used to synthesize 6ANAD from NAD and 6ANam. The procedure of Honjo 
and Nishizuka (62) was modified to accomplish the exchange reaction. 
Sixty millimoles of 6ANam and pig brain NADase was used instead of 
sixty millimoles of NA and beef spleen NADase. The NAD recycling 
assay measured the loss of NAD. The reaction is shown in Figure 5. 
NADase was also used in the identification of 6ANAD produced.!!!, 
vivo. 14 One milligram of 6ANAD- C was added to 0.5 ml of 0.1 M phosphate 
buffer and 10 milligrams of NADase. At various times 0.1 ml of solu-
tion was removed and 0.05 ml perchloric acid added to stop the reaction. 
The mixture was then analyzed on chromatography system V. 
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TABLE III 
THIN LAYER AND PAPER CHROMATOGRAPHY SYSTEMS 
Support System Solvent 
I Cellulose plate n-butanol sat. with H20: NH4 ,0H, 66:6 
II Cellulose plate n-butanol sat. with H2o: acetic acid, 66:3 
III Cellulose plate isobutyric acid: H20: NH40H, 66:33:1 
IV Cellulose/PEI 0.1 M LiCl 
v DE81 paper 
Figure 4. Reactions of Phosphodiesterase 
Pho1phodleatera11 
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I A 
NMN P-R 
, 
P-R t 
NAO P-RA AMP 
0 0 
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P - R P R 
I 
.P 
A 
R ., p 
+ 
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Reaction mixtures contain 0.15 mM pyridine nucleotide, 0.03 M 
MgC12 , and 100 mg of enzyme in 30 ml of NaHC03 buffer at 
pH 8.2. 
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Figure 5. Reactions of NAD glycohydrolase (NADase). 
See Text for Experimental Conditions. 
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Chemicals 
The K14CN (lmCi/mg) utilized in the synthesis of 6ANA- 14c and 
6ANam-14c, and the NA-14c were obtained from New England Nuclear. 
6ANam, NA, NAm, phosphodiesterase, NAD glycohydrolase, and alcohol 
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dehydrogenase were purchased from the Sigma Company. PABA was purchased 
from Eastman Organic Chemicals. 2~Amino-5-nitro-pyridine was obtained 
from Aldrich Company, PPO and POPOP were obtained from the Packard 
Instrument Company. All other chemicals were obtained from major 
supply houses. 
CHAPTER IV 
RESULTS AND DISCUSSION 
. 14 14 Conversion of 6ANA- C to 6ANam- C 
The initial experiment (Figure 6) concerned the conversion of 
6ANA to 6ANam in mutant W3899n. Because of the nicotinamide deaminase 
block, Nam is excreted into the medium when the cells are incubated 
in the presence of. NA. Therefore, if 6ANam is excreted when the 
bacteria are fed 6ANA, then this analogue must have gone through the 
pyridine nucleotide cycle. Ten ml cultures of cells were incubated 
with 2 X 10-4 M 6ANA-14c for six hours. After the cells were removed 
from the medium, 1 ml each of 10-3 M 6ANA and 10-3 M 6ANam were added 
to the medium. The medium was placed on a Dowex 1 formate column and 
eluted according to the procedure in the Methods. The fractions were 
14 
monitored for absorbance at A260 and C content.. Two radioactive 
peaks were observed, Figure 7. These peaks, one eluting with water 
and the other with formate, coincided with the absorbance peaks of 
6ANam and 6ANA respecitvely. Using thin layer chromatrography with 
systems I and II. For identification, the peak eluting with·water was 
shown to be 6ANam and the peak eluting with formate was 6ANA. The peak 
eluting with water was also hydrolyzed using lN NaOH and the product 
was 6ANA using systems I and II. 
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Figure 6. The Excretion of Nam-14c from Cells Incubated with 
NA-14c. See Text for Experimental Details. 
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Figure 7. The Excretion of 6ANam- 14c from Cells 
Incubated with 6ANA-14c. 
31 
II 00 
1.0 
.9 H 0 900 
.8 
.7 700 
.6 cplll 
A2ao .!5 !500 
.4 
,3 300 
.2 
,I 100 
Fraction no. (4 ml ) 
The medium from!· £21!. W3899n cells incubated with 2 X 10-~ 6ANA-14c 
was run on a Dowex 1 X 8 formate column 35cm X lcm. The column was 
eluted with H2o and lN formic acid. 4 ml fractions were collected. 
0------0 = cpm; Ct:.'."'""---c = absorbance at 260nm 
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Cell Concentration 
The concentration of W3899n used in these experiments was 109 
cells/ml to 4 X 109 cells/ml. This optimum range (Figure 8) was 
determined by incubating the cells at various concentrations and 
checking for the conversion of 6ANA to 6ANam by ion exchange 
chromatography. As cell concentration increases the amount of 14c 
remaining in the medium, continuously decreases. However, the maximum 
excretion of 6ANam-14c occured at a concentration range of 
1 X 109-2 X 109 cells/ml which is the normal concentration of cells in 
late log phase. 
Table IV shows the increase in numbers of cells/ml in the incuba-
tion cultures as determined by plate counts. The blank (no NA or 6ANA 
added) and the 6ANA experiments showed only growth from residual NA 
present. The NA experiment, however, showed that the W3899n was still 
in log phase. 
Effect of Time Coure on Incubation 
14 . 14 The time course of 6ANA- C uptake (Figure 9) and 6ANam- C 
excretion was then determined. W3899n was incubated in a 100 ml 
culture containing 2 X l0-4M 6ANA- 14c. At designated times 1 ml 
aliquots were removed and centrifuged using an International Clinical 
"f 4°. centri uge at An aliquot of the supernatant (O.l ml) was counted 
and 0.1 ml was analyzed by thin layter chromatography system I. The 
plates were scraped and the scrapings counted for 14c. Initial 
difference in total dpm in supernat and in 6ANA dpm lies in experimental 
error. 
Figure 8. Determination of Optimum Cell Concentration for 
Excretion of 6ANam-14c. 
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2 3 4 5 6 7 8 
cone cells ( x 109 J 
c Total dpm in medium 
0 dpm of 6ANam-14c in medium 
Blank 
NA 
6ANA 
a See 
TABLE IV 
CELL COUNTS AFTER 6 HOURS OF INCUBATION 
WITH TEST CCMPOUNDS8 
cells/ml X 109 cells/ml X 109 
t=O t=6 
3.3 8.2 
2.7 9.3 
2.9 7.7 
text for experimental details. 
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Figure 9. Determination of Time Required to Accumulate 6ANA-14c 
Compounds in Cells 
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After an initial lag, the 6ANA-14c is taken up by the cells. 
After about 90 minutes 6ANam-14c appears in the supernatant but at a 
slower rate than the disappearance of 6ANA-14c. Therefore, a 14c 
compound or compounds accumulate inside the cell. After six hours 
approximately 50% of the 14c is inside the cells. 10% of the 14c was 
14 lost presumably as co2 or perchloric acid insoluble compounds. 
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NA-14c, on the other hand, is taken into the cell very rapi~ly for 
90 minutes. At this time the rate of uptake is greatly decreased. 
See Figure 10. All 14c was recovered in the medium or in the perchloric 
acid soluble cellular extract. 
Excretion Controls 
Control experiments were run to show that W3899n (nad B pnc A) did 
14 14 14 
not excrete any C compounds upon incubation with 6ANam- C or Nam- C. 
In addition to W3899n, W3899 (nad B) was checked. In each case the 
supernatant was analyzed for the acid and corresponding amide. It was 
seen that W3899n cannot produce acid from amide while W3899 (nico-
tinamide deaminase present) can produce acid from amide. Both mutants 
produce and excrete amide (6ANam-14c and Nam-14c) from acid (6ANA-14c 
and NA-14c). 
Perchloric Acid Soluble Cellular Compounds 
Because 6ANA is a structural analogue of paraaminobenzoic acid 
(PABA), it can be incorporated into a folic acid analogue. To study 
only the effects of 6ANA on the pyridine nucleotide cycle, PABA was 
-3 
added to the incubation mixture to a concentration of 10 M to prevent 
formation of the folic acid analogue of 6ANA. Results of 
Figure 10. 14 The Time Course of Uptake of NA- c.and Excretion of 
Nam-14c. See Text for Experimental Detail, 
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Dowex-1-Formate chromatography of the perchloric acid soluble cell 
extract of cells incubated with 6ANA-14c and with/without PABA are 
shwon in figures 11 and 12 respectively. Only the sixth peak on each 
profile is changed. Two separate compounds are found with 6ANA- 14c 
and only one with 6ANA-14c.and PABA·only one. 
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14 The perchloric acid soluble fraction of cell extracts from 6ANA- C 
14 plus PABA and NA- C experiments were also chromatographed on Dowex 1 
formate columns. 14 In the case of 6ANA- C, seven radioactive peaks were 
observed (Figures 13 & 14). With NA-14c five radioactive peaks were 
observed. The NA-14c metabolites were identified using cold authenic 
compounds on ion exchange chromatography, thin layer and paper 
chromatography Systems I and V. The Rf values are shown in Table V. 
Peak I is Nam; Pe~k !I is NA; Peak III is NAD; Peak Vis NADP; Peak IV 
is unassigned. 
Identification of 6ANAD 
Peak V of.the 6ANA-14c cell extract contains the highest total 
· ' 14 , 
activity of the·6ANA- C metabolites. This peak also contains as de-
tected NAD by the cycling assay and, therefore, was subjected to further 
investigation. The peak was placed on a DEAE cellulose-HC03 column 
which was eluted with water and then 'til'ith a NH4Hco3 gradient. The 
radioactive material eluted with water and at the beginning of the 
gradient. The NAD is eluted from the column (Figure 15) when the 
conductivity of the elution reaches 2 mmho. The radioactive peak 
eluting with bicarbonate was further purified over the same column again. 
Again a small 14c peak was eluted with H2o and the major 14c peak with 
(Figure 16). Formation of first peak is evidence that the major peak 
Figure 11. Anion Exchange Chromato!raphy of Extract from Cells 
Incubated with 6ANA-1 C and PABA. See Text for 
Experimental Procedures. 
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Figure 12. Anion Exchange Chromatography of Extract from Cell 
Incubated with 6ANA-14c but without PABA. See 
Text for Experimental Details. 
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Figure 13. Anion Exchange Chromatography of Perchloric Acid 
Soluble Cell Extract from Cells Incubated with 
6ANA-14c. See Text for Experimental 
procedure. 
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Figure 14. Anion Exchange Chromatography of Perchloric Acid Soluble 
Cell Extract from Cells Incubated with NA-14c. See 
Text for Experimental procedure. 
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TABLE V 
CHROMATOGRAPHY OF NAD- 14c CCMPOUNDS 
System 
Compound I v 
NA .29 .51 
Nam .78 .76 
NMN .00 .79 
NAD .00 .61 
NADP .00 .27 
I .74 .75 
II .28 .48 
III .00 .57 
IV .52 
v .00 .29 
Figure 15. Presumed 6ANAD Analyzed on DEAE Cellulose Column. 
See Text for Experimental Detail1:1. 
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Figure 16. Second Purification of 6ANAD on DEAE Cellulose 
Column. See Text for Experimental Details. 
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(presumably 6ANAD) breaks down with time. 
The peak eluted with bicarbonate was hydrolyzed with snake venom 
phosphodiesterase and with NADase. The product from the former reac-
tion was analyzed on a 5cm X .2cm Dowex 1 X 2 formate column (Figure 
17). 14 The C compound was eluted with water and checked in 
chromatography systems I, II, III, IV, and V, and has a different Rf 
from the starting material. Se Table VI. 14 The C product of the 
phosphodiesterase reaction is presumed to be 6ANMN. 
h A l4 · d - h k d Te N Dase C reaction pro ucts were c ec e on system Vat 
various times along with authentic 6ANam. The 6ANam has an Rf of 0.50 
in this system and the suspected 6ANAD as an Rf of 0.75. NAD has an Rf 
of 0.74 in this system. From Table VI it is seen that at time O the 
suspected 6ANAD had partially broken down into 6ANam. However, with 
14 time the C compound with Rf 0.75 disappears from the solution, thus, 
showing hydrolysis of that compound. This compound is, thus, tenatively 
identified as 6ANAD. 
14 Other C Compounds 
14 When cells of W3899n were incubated in the presence of NA- C 
five radioactive peaks were found on Dowex-1 formate chromatography of 
the cellular extract. Table VII in contrast, seven intracellular 
radioactive peaks were found after incubating with 6ANA-14c. Most of 
14 the compounds formed from 6ANA- C remain unidentified. 
From results obtained with chromatography system I (Table VII) 
6ANam-14c is not found as a component of any of the peaks of the 
cellular extract except as a breakdown product of peak V. The 
phosphodiesterase product of 6ANAD (6ANMN) was also not observed in the 
Figure 17. Chromatography of Phosphodiesterase Hydrolysate on 
Dowex 1 Formate Column. See Text for 
Experimental Detail. 
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TABLE VI 
NADase HYDROLYSIS OF SUSPECTED 6ANAD 
Cm 
Time RF .58 RF • 71 
0 3222 1440 
20 2053 1315 
40 2660 603 
120 2915 235 
6ANam 5521 
Peak 
I 
II 
III 
IV 
v 
VI 
VII 
6ANA 
6ANam 
6ANAD 
TABLE VII 
Rf VALUES OF 6ANA-14c METABOLITES ON SEVERAL 
CHROMATOGRAPHY SYSTEMS 
System 
I II III IV 
.81 .87 .79 
.75 .75 .93 .86 
.38 .75 .80 .07 
.25 • 7 5 .80/.27 .43/.86 
.oo .00 .68/.93 .43 
.00 .00 .43 
.00 .36/.79 
.06 .85 
.50 .80 
.00 .00 .69 
Phosphodiesterase .00 .00 .62 
Product 
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v 
.93 
. 77 
.80 
.43 
.42/.77 
.47 
.77/.47 
.42 
.75 
.65 
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cellular extract. 
Possibilities for these other peaks are 6ANA riboside, 6ANam 
riboside, des 6ANAD, 6-amino-nicotinic acid mononucleotide and 6ANADP. 
Altered rates of the pyridine nucleotide cycle enzymes with the 
6-amino analogues might explain the 2 extra peaks observed with 6ANA-14c. 
That is the rates of metabolism and breakdown of the analogues could be 
altered such that a build up of some analogues could occur. Another 
possibility is that the analogues are much less stable than the natural 
pyridine nucleotides and break down into several compounds. 
CHAPTER V 
CONCLUSION 
14 14 
~· coli W3899n converts 6ANA- C to 6ANam- C. The excretion of 
6ANam- 14c is slower than the uptake of 6ANA-14c resulting in an 
accumulation of 14c compounds in the cell. The conversion of 6ANA to 
6ANam suggests that the 6ANA is metabolized through the pyridine 
nucleotide cycle, since this provides the only know sequency of reac-
tions for converting NA to Namide. A compound isolated from cells 
incubated with 6ANA treated cells which appears to be the 6-amino 
analogue of NAD. 
These findings support the hypothesis that the bacterostatic 
action of 6ANA is due to the conversion of 6ANA and 6ANam into pyridine 
nucleotide analogues which are not functional in oxido-reduction 
reactions and which repress and/or inhibit the biosynthesis of the 
normal pyridine nucleotides. 
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